Man Group’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Man Group’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-13,301	Closed	-$239K	–	2367
2022 Q3	$239K	Buy	+13,301	New	+$240K	﹤0.01%	1731

Other funds holding INBX

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Man Group's INBX Position: Q4 2022 in Review

Man Group sold out of Inhibrx, Inc. Common Stock (INBX) in Q4 2022, closing a stake of 13,301 shares — an estimated $239K sold.

Man Group first reported a position in INBX in Q3 2022 and held it in 1 quarter. The position peaked at $239K in Q3 2022. 116 funds tracked by Wall St. Rank hold INBX as of Q4 2022.

Man Group reported no remaining Inhibrx, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Man Group sold 13,301 Inhibrx, Inc. Common Stock shares in Q4 2022, an estimated $239K.
Man Group first reported a position in Inhibrx, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
Man Group's Inhibrx, Inc. Common Stock position peaked at $239K in Q3 2022.
116 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q4 2022.

Based on Man Group's 13F filing for Q4 2022, filed 14 Feb 2023.